Multifocal myoclonus as a presentation of levetiracetam toxicity
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Neurophysiology Practice"
DOI: 10.1016/j.cnp.2021.10.004
Abstract: Highlights • Levetiracetam (LEV) is a widely used antiseizure medication, but LEV toxicity is not commonly reported.• We report a patient with chronic kidney disease who developed multifocal myoclonus after treatment with LEV.• The findings… read more here.
Keywords: levetiracetam toxicity; myoclonus presentation; toxicity; presentation levetiracetam ... See more keywords